Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 1
2004 1
2005 2
2006 3
2007 1
2008 1
2009 1
2010 1
2011 1
2013 2
2014 1
2015 2
2016 1
2017 1
2018 2
2019 3
2020 3
2022 4
2023 5
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.
Zeckanovic A, Mouttet B, Vinti L, Ancliff P, Brethon B, Cario G, Elitzur S, Hazar V, Kunz J, Möricke A, Stein J, Yaman Y, Buechner J, Hjort MA, O'Connor D, Hodder A, Bartram J, Alten J, Barbaric D, Escherich G, Boissel N, Vasseur L, Clappier E, Farnault L, Bonnet S, Patrick K, Schrappe M, Anak S, Baruchel A, Locatelli F, Stanulla M, Von Stackelberg A, Bodmer N, Bourquin JP. Zeckanovic A, et al. Among authors: barbaric d. Haematologica. 2025 Jun 1;110(6):1373-1378. doi: 10.3324/haematol.2024.286111. Epub 2025 Feb 6. Haematologica. 2025. PMID: 39911115 Free PMC article. No abstract available.
Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009.
Barnbrock A, Möricke A, Barbaric D, Jones N, Koenig C, Moser R, Rohde M, Salvador C, Alten J, Elitzur S, Groll AH, Lehrnbecher T. Barnbrock A, et al. Among authors: barbaric d. Br J Haematol. 2024 Jun;204(6):2319-2323. doi: 10.1111/bjh.19382. Epub 2024 Mar 25. Br J Haematol. 2024. PMID: 38527954 Free article. Clinical Trial.
The recombinome of IKZF1 deletions in B-cell precursor ALL.
Lopes BA, Meyer C, Bouzada H, Külp M, Maciel ALT, Larghero P, Barbosa TC, Poubel CP, Barbieri C, Venn NC, Pozza LD, Barbaric D, Palmi C, Fazio G, Saitta C, Aguiar TF, Lins MM, Ikoma-Colturato MRV, Schramm M, Chapchap E, Cazzaniga G, Sutton R, Marschalek R, Emerenciano M. Lopes BA, et al. Among authors: barbaric d. Leukemia. 2023 Aug;37(8):1727-1731. doi: 10.1038/s41375-023-01935-8. Epub 2023 Jun 29. Leukemia. 2023. PMID: 37386080 No abstract available.
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V, Valsecchi MG, Cario G, Zimmermann M, Attarbaschi A, Stary J, Niggli F, Dalla Pozza L, Elitzur S, Silvestri D, Locatelli F, Möricke A, Engstler G, Smisek P, Bodmer N, Barbaric D, Izraeli S, Rizzari C, Boos J, Buldini B, Zucchetti M, von Stackelberg A, Matteo C, Lehrnbecher T, Lanvers-Kaminsky C, Cazzaniga G, Gruhn B, Biondi A, Schrappe M. Conter V, et al. Among authors: barbaric d. J Clin Oncol. 2024 Mar 10;42(8):915-926. doi: 10.1200/JCO.23.01388. Epub 2023 Dec 14. J Clin Oncol. 2024. PMID: 38096462
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy.
Cario G, Valsecchi MG, Conter V, Gotti G, Möricke A, Stanulla M, Vossen-Gajcy M, Lenk L, Stary J, Hrusak O, Dworzak M, Attarbaschi A, Barbaric D, Locatelli F, Bodmer N, Elitzur S, Silvestri D, Dalla-Pozza L, Fagioli F, Kulozik AE, Izraeli S, Rizzari C, Rademacher A, Buldini B, Bourquin JP, Zimmermann M, Schrappe M, Biondi A. Cario G, et al. Among authors: barbaric d. Hemasphere. 2025 Sep 2;9(9):e70206. doi: 10.1002/hem3.70206. eCollection 2025 Sep. Hemasphere. 2025. PMID: 40904487 Free PMC article.
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies.
Ceppi F, Gotti G, Möricke A, Silvestri D, Poyer F, Lentes J, Bergmann A, Trka J, Alten J, Elitzur S, Barbaric D, Buldini B, Dell'Acqua F, Schumacher F, Casazza G, Tchinda J, Nebral K, Conter V, Attarbaschi A, Schrappe M. Ceppi F, et al. Among authors: barbaric d. Eur J Cancer. 2022 Nov;175:120-124. doi: 10.1016/j.ejca.2022.08.013. Epub 2022 Sep 13. Eur J Cancer. 2022. PMID: 36113241 Free article.
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009.
Lehrnbecher T, Groll AH, Cesaro S, Alten J, Attarbaschi A, Barbaric D, Bodmer N, Conter V, Izraeli S, Mann G, Möricke A, Niggli F, Schrappe M, Stary J, Zapotocka E, Zimmermann M, Elitzur S. Lehrnbecher T, et al. Among authors: barbaric d. Leukemia. 2023 Jan;37(1):72-78. doi: 10.1038/s41375-022-01768-x. Epub 2022 Dec 12. Leukemia. 2023. PMID: 36509893 Free PMC article. Clinical Trial.
37 results